Medinet, University of Tokyo, Shin-Yokohama Medical Clinic Jointly Launch Clinical Studies of Activated Self Gamma-delta T Cell Therapy for Non-Small Cell Lung Cancer.Tokyo, Japan, Mar 1, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Medinet has signed a joint research agreement with the University of Tokyo “Todai” redirects here. For the restaurant called Todai, see Todai (restaurant). The University of Tokyo (東京大学 and Shin-Yokohama Medical Clinic. Under the terms of the agreement, the three partners will jointly undertake through March 2007 clinical studies of activated self gamma-delta T cell therapy, in which they aim to verify the safety and effectiveness of the therapy against non-small cell lung cancer Lung Cancer, Non-Small Cell Definition Non-small cell lung cancer (NSCLC) is a disease in which the cells of the lung tissues grow uncontrollably and form tumors. Description There are two kinds of lung cancers, primary and secondary. . The studies are designed for 10 patients who were treated for lung cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the leading cause of cancer death in the United States in both men and women. Like other cancers, lung cancer occurs after repeated insults to the genetic material of the cell. at the University of Tokyo hospital. Through these means, Medinet aims to establish a new cancer therapy at the earliest date possible. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion